What is refractory ascites (accumulation of fluid in the peritoneal cavity that is resistant to treatment)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Refractory ascites is a severe form of ascites that does not respond adequately to standard medical treatment, defined as ascites that cannot be mobilized or recurs after large-volume paracentesis despite dietary sodium restriction and diuretic therapy, and is associated with poor survival of 50% at 6 months 1.

Definition and Classification

Refractory ascites is further divided into two subgroups:

  • Diuretic-resistant ascites, which is ascites that is refractory to dietary sodium restriction and intensive diuretic treatment
  • Diuretic-intractable ascites, which is ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage 1.

Management

Patients with refractory ascites often require alternative management strategies such as:

  • Large-volume paracentesis (removal of 5-10 liters of fluid at once)
  • Transjugular intrahepatic portosystemic shunt (TIPS) placement
  • Consideration for liver transplantation in appropriate candidates 1. Albumin infusion (typically 6-8 g per liter of fluid removed) is recommended during large-volume paracentesis to prevent circulatory dysfunction 1.

Prognosis

Refractory ascites typically develops in advanced liver cirrhosis when portal hypertension becomes severe and is associated with poor prognosis, with mortality rates of approximately 50% within one year 1. The underlying mechanism involves severe portal hypertension, reduced effective arterial blood volume, and activation of sodium-retaining mechanisms that overwhelm the effectiveness of diuretics 1.

Evaluation for Liver Transplantation

Patients with refractory ascites should be evaluated for liver transplantation when appropriate, as this represents the definitive treatment for the underlying liver disease 1.

From the Research

Definition of Refractory Ascites

  • Refractory ascites is defined as ascites that does not respond or recurs after high-dose diuresis and sodium restriction 2, 3.
  • It is also characterized as fluid overload that is unresponsive to sodium-restricted diet and high-dose diuretic treatment (diuretic-resistant) or when there is an inability to reach maximal dose of diuretics because of adverse effects (diuretic-intractable) 3.

Causes and Mechanisms

  • Refractory ascites occurs in patients with functional renal failure as a consequence of alteration in both pharmacokinetics and pharmacodynamics of diuretics 4.
  • The complex hemodynamic alterations, including decrease in renal plasma flow and increased sodium reabsorption, lead to refractory ascites 2.

Treatment Options

  • The available therapies for refractory ascites are repeated large volume paracentesis (LVP), transjugular intrahepatic portosystemic shunts (TIPS), peritoneovenous shunts, investigational medical therapies, and liver transplantation 2, 4, 5, 3, 6.
  • LVP with concomitant volume expanders is the initial treatment of choice 2, 6.
  • TIPS seems to be superior to LVP in reducing the need for repeated paracentesis and improves the quality of life 2.
  • Liver transplantation remains the only definitive therapy for refractory ascites and should be considered and incorporated early in the treatment plan 2, 5, 3, 6.

Prognosis

  • Refractory ascites is a poor prognostic sign, with a 50% mortality rate within 6 months of its development 5.
  • The development of refractory ascites indicates progression of the underlying cirrhosis and is associated with a poor prognosis 2, 5, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of refractory ascites.

American journal of therapeutics, 2012

Research

Treatment of cirrhotic ascites.

Acta gastro-enterologica Belgica, 2007

Research

Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.

Acta gastro-enterologica Belgica, 1990

Research

Treatment of Ascites.

Current treatment options in gastroenterology, 2003

Research

Management of ascites in cirrhosis.

Journal of gastroenterology and hepatology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.